BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener
Sign in Register
Portfolio (Quarterly) Guide ↗

Breachway Investments LLC

· CIK 0002106661
13F Portfolio $66M AUM 74 positions Filed Jul 13, 2026 EDGAR ↗ ← All Funds
Q2 2026 Q1 2026 · All 4 New 16 Added 39 Reduced 26 Exited
# Ticker Company Sector Shares Value ↓ % Port Chg Shares Chg % Period Price ① Since Period ①
1 IBDU ISHARES TR 107,805.0 $2.5M 3.76% +3K +2.4% $23.16 -0.5%
2 EFA ISHARES TR 21,313.0 $2.2M 3.33% +335.0 +1.6% $103.88 +4.2%
3 IBDV ISHARES TR 86,205.0 $1.9M 2.83% +7K +8.2% $21.80 -0.9%
4 IWF ISHARES TR 13,168.0 $1.6M 2.46% +9K +244.6% $124.17 -1.4%
5 IBDW ISHARES TR 61,265.0 $1.3M 1.92% +8K +15.2% $20.84 -1.2%
6 PSK SPDR SERIES TRUST 27,975.0 $854K 1.29% +4K +17.8% $30.53 -3.1%
7 IBDX ISHARES TR 30,850.0 $777K 1.17% +8K +33.3% $25.19 -1.4%
8 VUG VANGUARD INDEX FDS 8,725.0 $752K 1.13% +7K +477.4% $86.14 +1.6%
9 VTI VANGUARD INDEX FDS 1,811.0 $670K 1.01% +18.0 +1.0% $370.04 +2.2%
10 IJS ISHARES TR 3,872.0 $529K 0.80% +60.0 +1.6% $136.68 +1.3%
11 IJK ISHARES TR 3,618.0 $425K 0.64% +80.0 +2.3% $117.50 -1.7%
12 VO VANGUARD INDEX FDS 4,868.0 $392K 0.59% +4K +300.0% $80.57 +3.0%
13 IJJ ISHARES TR 2,220.0 $328K 0.49% +70.0 +3.3% $147.73 +0.9%
14 VWO VANGUARD INTL EQUITY INDEX F 5,111.0 $305K 0.46% +145.0 +2.9% $59.69 +1.3%
15 HDV ISHARES TR 9,685.0 $265K 0.40% +4K +68.5% $27.41 +8.8%
16 IJT ISHARES TR 1,455.0 $260K 0.39% +45.0 +3.2% $178.60 -2.6%

Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.

Sector Allocation
Technology 42.6%
Financial Services 20.3%
Consumer Cyclical 12.2%
Healthcare 9.1%
Communication Services 7.2%
Industrials 5.2%
Consumer Defensive 3.4%